Evidence map›Paper›PMID 19366708›Full record

ArticleThe Journal of biological chemistry2009

Motogenic sites in human fibronectin are masked by long range interactions.

Ioannis Vakonakis, David Staunton, Ian R Ellis, Peter Sarkies, Aleksandra Flanagan, Ana M Schor, Seth L Schor, Iain D Campbell

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Opposing effects of collagen I and vitronectin on fibronectin fibril structure and function.Matrix biology : journal of the International Society for Matrix Biology · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ioannis VakonakisDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU , UK. ioannis.vakonakis@bioch.ox.ac.uk
David Staunton
Ian R Ellis
Peter Sarkies
Aleksandra Flanagan
Ana M Schor
Seth L Schor
Iain D Campbell
University of Oxford · GBUniversity of Dundee · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Fibronectin (FN) is a large extracellular matrix glycoprotein important for development and wound healing in vertebrates. Recent work has focused on the ability of FN fragments and embryonic or tumorigenic splicing variants to stimulate fibroblast migration into collagen gels. This activity has been localized to specific sites and is not exhibited by full-length FN. Here we show that an N-terminal FN fragment, spanning the migration stimulation sites and including the first three type III FN domains, also lacks this activity. A screen for interdomain interactions by solution-state NMR spectroscopy revealed specific contacts between the Fn N terminus and two of the type III domains. A single amino acid substitution, R222A, disrupts the strongest interaction, between domains (4-5)FnI and (3)FnIII, and restores motogenic activity to the FN N-terminal fragment. Anastellin, which promotes fibril formation, destabilizes (3)FnIII and disrupts the observed (4-5)FnI-(3)FnIII interaction. We discuss these findings in the context of the control of cellular activity through exposure of masked sites.

Indexed as

Alternative SplicingAmino Acid SubstitutionAnimalsCell LineChromatography, GelCollagenCytokinesEscherichia coliFibronectinsGenetic VariationHumansKidneyMagnetic Resonance SpectroscopyModels, MolecularPeptide FragmentsPichiaCollagenCytokinesFibronectinsFN1 protein, humanPeptide FragmentsRecombinant Proteins

Identifiers

PMID19366708
PMCPMC2708863
OpenAlexW1990611792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.